Hyperactivation of the AXL-ICD/SIRT2 axis by Amyloid-β impairs astrocytic autophagic flux and exacerbates neuroinflammation
The TAM receptor AXL is identified as a molecular transducer that couples Aβ sensing to the regulation of autophagy and neuroinflammation in astrocytes and proposed the AXL-ICD/SIRT2 axis as an effective therapeutic target to reduce Aβ burden and neuroinflammation in AD.